CANLI
Yükleniyor Veriler getiriliyor…
/ Makaleler / Scopus Detay
Scopus 🔓 Açık Erişim YÖKSİS DOI Eşleşti SJR Q3

The struggle against endometrial cancer: ten years of experience of a tertiary center

Ginekologia Polska · Ocak 2022

YÖKSİS DOI Eşleşmesi Bulundu

Bu Scopus makalesi YÖKSİS veritabanında da kayıtlı. Aşağıda YÖKSİS verilerini görebilirsiniz.

YÖKSİS Kayıtları
The struggle against endometrial cancer: ten years of experience of a tertiary center
GİNEKOLOGİA POLSKA · 2022 SCI-Expanded
Prof. Dr. ÇETİN ÇELİK →
The struggle against endometrial cancer: ten years of experience of a tertiary center
Ginekologia Polska · 2021 SCI-Expanded
Prof. Dr. ÇETİN ÇELİK →
The struggle against endometrial cancer: ten years of experience of a tertiary center
Ginekologia Polska · 2022 SCI-Expanded
Prof. Dr. ÇETİN ÇELİK →
The struggle against endometrial cancer: ten years of experience of a tertiary center
GİNEKOLOGİA POLSKA · 2022 SCI-Expanded
Prof. Dr. MEHMET KULHAN →
The struggle against endometrial cancer: ten years of experience of a tertiary center
Ginekologia Polska · 2021 SCI-Expanded
Doç. Dr. ERSİN ÇİNTESUN →
The struggle against endometrial cancer: ten years of experience of a tertiary center
Ginekologia Polska · 2022 SCI-Expanded
Doç. Dr. AHMET BİLGİ →
YÖKSİS ISSN Eşleşmesi

Bu dergide (ISSN eşleşmesi) kurumun 10 kaydı bulundu.

YÖKSİS Kayıtları — ISSN Eşleşmesi
Assessment of clinicopathological features evaluation of treatment and prognosis of clear cell and serous papillary endometrial carcinoma
2016 ISSN: 0017-0011 SCI-Expanded
Prof. Dr. MEHMET KULHAN →
Retrospective evaluation of clinical and pathological features as well as diagnostic and treatment protocols of primary vaginal malignancy
2016 ISSN: 0017-0011 SCI-Expanded
Prof. Dr. MEHMET KULHAN →
Urodynamic assessment of short term effects of pelvic radiotherapy on bladder function in patients with gynecologic cancers
2016 ISSN: 0017-0011 SCI-Expanded
Prof. Dr. MEHMET KULHAN →
Can neutrophil-lymphocyte and platelet-lymphocyte ratios predict threatened abortion and early pregnancy loss?
2020 ISSN: 0017-0011 SCI-Expanded
Prof. Dr. MEHMET KULHAN →
The struggle against endometrial cancer: ten years of experience of a tertiary center
2022 ISSN: 0017-0011 SCI-Expanded Q4
Prof. Dr. ÇETİN ÇELİK →
The struggle against endometrial cancer: ten years of experience of a tertiary center
2022 ISSN: 0017-0011 SCI-Expanded Q4
Doç. Dr. AHMET BİLGİ →
Classification of high-grade endometrium carcinomas using molecular and immunohistochemical methods
2023 ISSN: 0017-0011 SCI-Expanded Q3
Doç. Dr. ERSİN ÇİNTESUN →
Classification of high-grade endometrium carcinomas using molecular and immunohistochemical methods
2023 ISSN: 0017-0011 SCI-Expanded Q4
Prof. Dr. ÇETİN ÇELİK →
Endocervical polyps in high risk human papillomavirus infections
2022 ISSN: 0017-0011 SCI-Expanded Q4
Prof. Dr. FATİH KARA →
Classification of high-grade endometrium carcinomas using molecular and immunohistochemical methods
2023 ISSN: 0017-0011 SCI-Expanded Q4
Prof. Dr. ÇETİN ÇELİK →

Makale Bilgileri

ISSN00170011
Yayın TarihiOcak 2022
Cilt / Sayfa93 · 351-360
Erişim🔓 Açık Erişim
Özet Objectives: We aimed to investigate the clinical and pathological factors of our patients who were diagnosed with endometrial cancer in terms of prognosis. With this study, we present our 10 years of surgical experience in endometrial carcinoma cases. Material and methods: Four hundred twelve patients with endometrial carcinoma who applied to our center between 2010–2019 and that we followed up were evaluated retrospectively. Results: Most of the tumors were low-grade endometrioid malignancies. Non-endometrioid types accounted for 12.1% of cases. Lymph node dissection was performed in 395 of 412 patients (95.9%). 66 (16.01%) of the 412 patients died during the follow-up period in the study sample. Higher OS and DFS rates were associated with endometrioid histological types, FIGO stage, absence of lymphovascular space invasion, lower grade and less than 50% myometrial invasion (p < 0.05). 5-year OS at stage 1, 2, 3, 4 was found as 88.9 ± 2.2%, 65.5 ± 10.8%, 49.4 ± 0.79% and 23.7 ± 0.97% respectively. 5-year DFS at stage 1, 2, 3, 4 was found as 84.1 ± 2.6%, 65.5 ± 10.8%, 47.7 ± 0.78% and 23.7 ± 0.97% respectively. In univariate analysis, Age, tumor histology, FIGO stage, histological grade, LVSI, positive peritoneal cytology, cervical involvement, myometrial invasion and not receiving adjuvant therapy were defined as prognostic factors. Conclusions: Age, grade, FIGO stage, myometrial invasion, histological type, LVSI involvement, cervical involvemet, positive peritoneal cytology and not receiving adjuvant therapy are important prognostic factors for progression-free survival and overall survival in patients diagnosed with endometrial cancer

Yazarlar (6)

1
A. Bilgi
ORCID: 0000-0001-8682-1739
2
A. H. Guler
ORCID: 0000-0002-7708-2302
3
Mehmet Kulhan
ORCID: 0000-0002-5478-7510
4
Ersin Çintesun
ORCID: 0000-0001-8507-5850
5
M. C. Ates
ORCID: 0000-0002-7977-2526
6
Çetin Çelik
ORCID: 0000-0001-6165-5092

Anahtar Kelimeler

Endometrial carcinoma Lymph node Prognostic factors Stage

Kurumlar

Selçuk Üniversitesi
Selçuklu Turkey
Scimago Dergi (ISSN Eşleşmesi)
Ginekologia Polska
Q3 OA
SJR Skoru0,399
H-Index33
YayıncıVia Medica
ÜlkePoland
Obstetrics and Gynecology (Q3)
Dergi sayfasına git

Metrikler

2
Atıf
6
Yazar
4
Anahtar Kelime

Sistemimizdeki Yazarlar